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INTRODUCTION
Fungal infections have become an alarming problem over the last ten years mainly because of global increase in the number of immunocompromised patients, who are highly susceptible to opportunistic infections, including mycoses 1 . According to a recent study, the incidence of Candidaemia is 6.9 per 1,000 ICU patients of which 7.5% received antifungal therapy 2 . Among the women, vaginal candidiasis has become a common finding worldwide and up to 75% of them have symptomatic vaginal candidiasis at least once 3 . Vulvovaginal candidiasis (VVC) is defined as signs and symptoms of inflammation of the vulva and vagina in the presence of Candida spp. and in the absence of other infectious etiology 4 . The clinical features of VVC include pruritus, hyperemia, vaginal discomfort and leucorrhea, burning, soreness, dyspareunia and vaginal or vulvar erythema, which may cause a problem in marital and sexual relations 5 .
Candida albicans appears to be the cause for 80 to 92 percent of vulvovaginal candidiasis 6 . There is an increase in frequency of other candida species nowadays, specifically of C. glabrata, may be because of increased use of over-the counter drugs, long-term use of azoles, and the use of short courses of antifungal drugs 7 . The prevalence of candida in India is estimated to be 30% 8 . There are various predisposing factors of VVC, few of which are, hormonal fluctuations in pregnancy, luteal phase of menstrual cycle, use of oral contraceptives, and hormone replacement therapy 9 .
Candida albicans is considered as an important fungal pathogen among humans because of its varying virulence factors that leads to candidiasis like phenotypic switching, phospholipase, proteinase and hemolytic activity. 85-90% of all cases of vulvovaginal candidiasis shows C.albicans followed by C.glabrata (5-10%), C. tropicalis (3-5%) and other species 10 . Though VVC is one of the most common fungal disease worldwide, the information about the distribution and etiology of it is scarcely known to us, because microbiology tests to identify the species of Candida and their antifungal susceptibility testing are not routinely performed in most of the laboratories 11 . Hence, this study is undertaken to determine the species specific prevalence and the risk factors associated with occurrence of VVC.
MATERIALS AND METHODS
This study was conducted in a tertiary care hospital in Chennai over a period of 1 year. The present study enrolled 160 patients attending the Obstetrics and Gynaecology Out patients department and Inpatients admitted in the wards with symptoms suggestive of vaginitis. The study has been approved by institutional ethical committee and Informed consent was obtained from all the subjects.
Sterile vaginal swabs were used for collection of vaginal samples from the patients. Two high vaginal swab samples were collected aseptically from the posterior vaginal fornix using speculum and posterior vaginal wall retractor. The swabs were transferred to the microbiology laboratory and processed immediately.
One of the swabs was used for Gram stain and direct wet mount microscopy using 10% Potassium hydroxide solution to determine the presence of yeast cells in the sample. The second swab was streaked on Sabouraud Dextrose agar (SDA) ( HiMedia, India ) plates containing chloramphenicol and incubated at 37 o C for 24-48 hours. The colonies from SDA plate were subjected to Gram stain to confirm the growth of candida and were further subtyped by streaking on Hichrome Candida differential agar ( HiMedia, India ) and incubated at 37 o C for 24-48 hours. The pigmented colonies were further examined for assimilation of various sugars and candida species were identified using standard microbiological methods. The colonies from the SDA plate were again processed in automated VITEK2 compact (bioMérieux) and the results were documented.
The colonies from SDA plate were also subjected to germ tube test to check for the production of germ tubes. Germ tube test is done by mixing 3-4 colonies in 0.5 ml human serum and incubated at 37 o C for 2-4 hours and examined under microscope for the formation of germ tube. Colonies suggestive of C.albicans were confirmed by this germ tube test.
RESULTS
A total of 160 women with complaints suggestive of vulvovaginal infections were enrolled in the present study. Their age ranged from 15 -65 years (table -1). In our study 51 women presented with complaints of white discharge (32%), 45 women (28%) had complaints of itching and 18 women (11%) had pain.
DISCUSSION
Vaginitis is a universal problem affecting millions of women globally. Vulvovaginal candidiasis (VVC) is defined as signs and symptoms of inflammation of the vulva and vagina in the presence of Candida spp. and in the absence of other infectious etiology 12 .
It is an established fact that C.albicans can convert into a disease causing pathogen from a commensal, when there is a change in the host environment 13 . The increasing antifungal resistance leading to treatment failures and added mortality warrant the need for identification of species in candida. The incidence is more common in women with diabetes where high blood sugars favour growth of candida. Other common associations for the predisposition of candida include pregnancy, antibiotic use and rarely infections like Tuberculosis.
In our study of 160 women, 56 high vaginal swabs (35%) were culture positive and grew candida species. This data is similar to reports by Kumari et al (30.6%), but lower than reports from Namrata Kalia et al (47%) and ranks second as the cause for vulvo vaginal infections 14 .
Among the 56 women with positive cultures, 20 were pregnant (35%), 6 women were diabetic (11%), 4 had a history of antibiotic use (7%), and 4 were taking Oral contraceptive pills (OCP) (7%). In our study, there was significant association of positive cultures with pregnancy which could be attributed to high levels of reproductive hormones inducing higher glycogen content in vaginal epithelial cells favouring growth of candida. Some studies say that estrogens have a direct effect on the growth of Candida and its adherence to the vaginal epithelium which explain the increased incidence in women using OCPs 15, 16 .
The other major risk factor is diabetes where the likely reasons could be due to uncontrolled blood sugars and also the use of unsuitable antifungal agents 17 . The use of antibiotics acts as a short term risk factor for the symptomatic vulvovaginal candidiasis due to the loss of lactobacilli and other normal flora in the vaginal surface 18 .
Most patients who seek medical attention have complaints of white discharge, itching and pain. In our study 51 women had complaints of white discharge (32%) which was the major complaint. It was followed by complaints of itching which was seen in 45 women (28%) and complaints of pain by 18 women (11%). The clinical presentation was slightly different from reports by Latha ragunathan et al 19 , where itching (31%) was the major complaint followed by white discharge (29.4%) and pain (15.6%).
In our study identification of candida species was done by conventional methods and confirmed by Vitek 2 compact. There were various candida species detected in our study with highest being C. albicans (44%), and non albicans (56%). Our study showed results similar to study by Kumari et al 12 and studies from other parts of the world where there was a higher prevalence of non albicans species 20, 21, 22 . This shows the increasing trend of non albicans species, which could be due to environmental variation. The increasing frequency warrants the need to identify the species and test the anti-fungal susceptibility to commonly used antifungal drugs.
The prevalence of non albicans species in our study were as follows C.tropicalis -20 (36%), C.glabrata -6 (11%), C.parapsilosis -4 (7%), C.krusei -1 (2%). Among the NAC (Non albicans Candida) C.tropicalis was the predominant species followed by C.glabrata which was similar to studies by Jayalakshmi et al 23 and Sundar Khadka et al 24 , but there was a slight difference in the study by Faraji et al 17 where candida was isolated from diabetic women only. The predominant Non albicans species was C.glabrata followed by C.tropicalis in the study by Sundar Kadka et al 24 .
The other species C.parapsilosis, C.krusei have been reported less frequently in patients with vulvovaginitis similar to our study 23 .
Thus, this study shows a changing trend in the causative agents of VVC. Increasing emergence and spread of various non albicans candida is a major concern in the management of VVC.
CONCLUSION
Candida albicans was found to be the predominant species isolated in the current study followed by C.tropicalis. Yet, there is higher prevalence of non albicans candida species in the study. Hence, screening of all women with vulvovaginal infections for different species of candida would be helpful in providing better care. Thus, complete identification of causative agent of Vulvovaginal candidiasis upto species level in all the microbiology laboratories is highly recommended in order to study the emergence and spread of non albicans candida in the community. More intensive studies are needed to determine the optimal treatment of antifungal drugs for VVC caused by non albicans species.
